The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up.

Source:http://linkedlifedata.com/resource/pubmed/id/19132970

Aliment. Pharmacol. Ther. 2009 Feb 1 29 3 286-97

Download in:

View as

Triples

General Info

PMID
19132970